Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Moderna requests emergency authorization from FDA for mRNA – 1273

Lapatinib, Doramapimod with Remdesivir teamed against COVID-19

Eli Lilly Life Science Publishing Specialist Recruitment | Apply Online

Moderna requests emergency authorization from FDA for mRNA – 1273
  • BiotechToday
  • World

Moderna requests emergency authorization from FDA for mRNA – 1273

bioxone December 1, 2020December 1, 2020

Prama Ghosh, Amity University Kolkata

The Cambridge, Massachusetts – based Biotech Company, Moderna asked for emergency authorization from the U.S. Food and Drug Administration to use its COVID – 19 vaccines, mRNA – 1273, after receiving confirmation about its safety and efficacy on Monday. According to a new study, the shots offer a strong protection and will be helpful in providing limited vaccination in the times of coronavirus.

According to the clinical trial consisting of 196 people with COVID – 19, 185 of them had received the dummy shots and only 11 received the active vaccine, bringing the effectiveness rate of the vaccine above 94%. 30 participants, all in the placebo group who suffered severely from the disease, suggest that the vaccine can be used to treat both mild and serious forms of the disease. A single death from the placebo group has been recorded. The report was confirmed by Dr. Tal Zaks, the Cambridge, and Massachusetts chief medical officer. Only temporary side effects like flu were recorded.

Moderna will be the second company to ask for authorization after Pfizer and its German partner BioNTech from the federal government. The British Biotech company expects a discussion on mRNA – 1273 from the FDA’s advisory committee on December 17, a week after discussing Pfizer’s vaccine. The authorization is expected to come a few days after each meeting.

Dr. Peter Hotez, a paediatrician and co – director of the Texas Children’s Hospital Center for Vaccine development and Moderna’s president, Dr. Stephen Hoge, were impressed with the efficacy of the vaccine and emphasized on the success of developing the vaccine in such a short period of time. Around 80 million doses will be provided for U.S. next year.

Also read: Lapatinib, Doramapimod with Remdesivir teamed against COVID-19

Reference: 1) https://www.thehindu.com/sci-tech/health/moderna-asking-us-european-regulators-to-ok-its-virus-shots/article33213883.ece

2) https://www.usatoday.com/story/news/health/2020/11/30/moderna-emergency-fda-authorization-covid-19-vaccine-pfizer/6376336002/

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Clinical trial corona virus COVID – 19 COVID – 19 vaccines FDA mRNA – 1273 vaccination vaccine doses

One thought on “Moderna requests emergency authorization from FDA for mRNA – 1273”

  1. Pingback: Ever wondered how the Rho protein really stops gene expression - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Eli Lilly Life Science Publishing Specialist Recruitment | Apply Online

bioxone December 2, 2020

-Shristi Sharma, Team bioXone Eli Lilly Job – Life Science Publishing Specialist Recruitment. Life Science eCTD publishing specialist Job Opening. Interested and eligible applicants can check out all of the details on the same  below: Name of the Post: eCTD publishing specialist Req ID: R-6271 Location: Bengaluru, Karnataka, India Purpose: The Central Regulatory Registration (CRR) […]

Related Post

  • BiotechToday
  • World

Y chromosome in the little guppy fish: How did it evolve?

DNA tales August 12, 2021August 11, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University A eukaryotic cell can divide in two ways- either by mitosis or by meiosis. Mitosis leads to the formation of daughter cells identical to parent cells. While meiosis leads to the generation of daughter cells that are different from the parent cells. These differences are brought about […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Haploflow: Tracing the disease back to its Origin

BioTech Today July 22, 2021July 21, 2021

Agrima Bhatt, Rajasthan University In the last few decades, humankind has gone through major healthcare upheavals causing a large amount of death and destruction. Epidemics, pandemics have come, some have passed with time but some have evolved to stay. And as we continue forward, scientists are already predicting the next pandemic to come soon. In […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

TINY platform uses HDA to detect Tuberculosis rapidly

BioTech Today June 21, 2021June 20, 2021

Souradip Mallick, National Institute of Technology, Rourkela Tuberculosis Disease (TB) is a major infectious disease with a high rate of morbidity and mortality. TB is one of the tenth leading causes of death worldwide ranking above HIV/AIDS. The World Health Organization (WHO) estimated that about 1.66 million people died from TB in 2020. Thus, various […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy